Skip to content
LexBuild

Bulk Manufacturer of Controlled Substances Application: SpecGx LLC; Correction

---
identifier: "/us/fr/2023-19179"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Bulk Manufacturer of Controlled Substances Application: SpecGx LLC; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2023-19179"
section_name: "Bulk Manufacturer of Controlled Substances Application: SpecGx LLC; Correction"
positive_law: false
currency: "2023-09-06"
last_updated: "2023-09-06"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Justice Department"
document_number: "2023-19179"
document_type: "notice"
publication_date: "2023-09-06"
agencies:
  - "Justice Department"
  - "Drug Enforcement Administration"
fr_citation: "88 FR 60987"
fr_volume: 88
docket_ids:
  - "Docket No. DEA-1176"
fr_action: "Notice; correction."
---

#  Bulk Manufacturer of Controlled Substances Application: SpecGx LLC; Correction

**AGENCY:**

Drug Enforcement Administration, Justice.

**ACTION:**

Notice; correction.

**SUMMARY:**

The Drug Enforcement Administration (DEA) published a document in the *Federal Register* of April 4, 2023, concerning a notice of application for bulk manufacturer of Controlled Substances. That document listed a drug code/controlled substance in error as it was not requested by the registrant (2270—Pentobarbital). Additionally, the document listed duplicates of 7 other drug codes in error (1100, 1105, 1205, 1724, 8333, 9780, 9801).

**SUPPLEMENTARY INFORMATION:**

**Correction**

In the *Federal Register* of April 4, 2023, in FR Doc. 2023-06952 (88 FR 19990), on page 19990, in columns 1 and 2, under the requested controlled substances/drug codes, it should read as such:

| Controlled substance | Drug code | Schedule |
| --- | --- | --- |
| Gamma Hydroxybutyric Acid | 2010 | I |
| Tetrahydrocannabinols | 7370 | I |
| Psilocybin | 7437 | I |
| Codeine-N-oxide | 9053 | I |
| Noroxymorphone | 9145 | I |
| Difenoxin | 9168 | I |
| Morphine-N-oxide | 9307 | I |
| Normorphine | 9313 | I |
| Alphamethadol | 9605 | I |
| Betamethadol | 9609 | I |
| Norlevorphanol | 9634 | I |
| Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) | 9821 | I |
| Butyryl Fentanyl | 9822 | I |
| Fentanyl related-compounds as defined in 21 CFR 1308.11(h) | 9850 | I |
| Amphetamine | 1100 | II |
| Methamphetamine | 1105 | II |
| Lisdexamfetamine | 1205 | II |
| Methylphenidate | 1724 | II |
| Nabilone | 7379 | II |
| ANPP (4-Anilino-N-phenethyl-4-piperidine) | 8333 | II |
| Phenylacetone | 8501 | II |
| Codeine | 9050 | II |
| Dihydrocodeine | 9120 | II |
| Oxycodone | 9143 | II |
| Hydromorphone | 9150 | II |
| Diphenoxylate | 9170 | II |
| Ecgonine | 9180 | II |
| Hydrocodone | 9193 | II |
| Levorphanol | 9220 | II |
| Isomethadone | 9226 | II |
| Meperidine | 9230 | II |
| Meperidine intermediate-A | 9232 | II |
| Meperidine intermediate-B | 9233 | II |
| Meperidine intermediate-C | 9234 | II |
| Methadone | 9250 | II |
| Methadone intermediate | 9254 | II |
| Dextropropoxyphene, bulk (non-dosage forms) | 9273 | II |
| Morphine | 9300 | II |
| Oripavine | 9330 | II |
| Thebaine | 9333 | II |
| Opium tincture | 9630 | II |
| Opium, powdered | 9639 | II |
| Oxymorphone | 9652 | II |
| Noroxymorphone | 9668 | II |
| Alfentanil | 9737 | II |
| Remifentanil | 9739 | II |
| Sufentanil | 9740 | II |
| Tapentadol | 9780 | II |
| Fentanyl | 9801 | II |

Claude Redd,

Acting Deputy Assistant Administrator.